Florence I. Raynaud

123 Old Brompton Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications

Impact of Daily Rhythms and Postprandial Responses on the Plasma Metabolome.

Impact of Daily Rhythms and Postprandial Responses on the Plasma Metabolome.

Journal: International journal of molecular sciences
Published: May 21, 2026

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.

Journal: Investigational new drugs
Published: February 04, 2026

Correction: AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity.

Correction: AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 19, 2025

WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth.

WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth.

Journal: Nature communications
Published: May 13, 2024

Erratum: iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells.

Erratum: iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells.

Journal: iScience
Published: April 22, 2024

Exposing 24-hour cycles in bile acids of male humans.

Exposing 24-hour cycles in bile acids of male humans.

Journal: Nature communications
Published: March 21, 2024

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Journal: Nature communications
Published: March 07, 2024

Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase.

Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase.

Journal: Journal of medicinal chemistry
Published: January 10, 2024

Characterizing functional DNA damage and response caused by the combination of CHK1 and WEE1 inhibitors in ovarian and breast cancer models.

Characterizing functional DNA damage and response caused by the combination of CHK1 and WEE1 inhibitors in ovarian and breast cancer models.

Journal: BJC reports
Published: October 19, 2023

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.

Journal: Cancer cell
Published: July 11, 2023

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.

Journal: Immunity
Published: July 10, 2023

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Journal: Nature
Published: May 23, 2023
Showing 1-12 of 101

Last Updated: 09/26/2026